Hannah R. Abrams
LightNews LightNews
hannahrabrams.bsky.social
Hannah R. Abrams
@hannahrabrams.bsky.social
2.3K followers 380 following 150 posts
Heme/Onc fellow at Fred Hutch, hoping to reduce costs & improve patient/caregiver experiences in cancer care. Social Media Editor @ JCO OP. Views are my own. #MedSky
Posts Replies Media Videos
hannahrabrams.bsky.social
(At age 55 for those numbers). Full paper from Southern Community Cohort Study here: jamanetwork.com/journals/jam...
Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers
This cohort study uses data from the Southern Community Cohort Study to evaluate whether race-specific adjustment of pack-year criteria in the US Preventive Services Task Force (USPSTF) lung cancer sc...
jamanetwork.com
November 25, 2025 at 8:42 PM
Reposted by Hannah R. Abrams
kiwiskinz.bsky.social
Sorry @erictopol.bsky.social it doesn't. All participants were normal coffee drinkers. Therefore, the coffee-drinker arm is the Control arm. The intervention of going cold turkey increased the hazard of AF by 64% (100/0.61). The whole report is written from the wrong perspective.
November 10, 2025 at 12:02 AM
hannahrabrams.bsky.social
Of patients who did restart treatment, 39% died or transitioned to hospice before next scan.

More from the publication here:
ascopubs.org/doi/10.1200/...
Return to Intended Oncologic Therapy in Patients With Metastatic Non–Small Cell Lung Cancer Discharged to a Skilled Nursing Facility | JCO Oncology Practice
PURPOSEHospitalized patients with metastatic non–small cell lung cancer (mNSCLC) and poor performance status are commonly discharged to a skilled nursing facility (SNF) to undergo rehabilitation,…
ascopubs.org
November 21, 2025 at 4:50 AM
hannahrabrams.bsky.social
So sorry to hear that - and in some ways so frustrating that this limited time is being filled up with mychart admin tasks. Wishing the best for you both.
November 21, 2025 at 4:48 AM
Reposted by Hannah R. Abrams
fumikochino.bsky.social
"our report highlights the need for our professional societies and abstract reviewers to cultivate greater awareness and adherence to patient-respectful language"
Original research from @narjustflorezmd.bsky.social @jco-asco.bsky.social @ascocancer.bsky.social

ascopubs.org/doi/10.1200/...
TABLE 1. Examples of Noncompliant Statements on the Basis of Individual Clauses of the ASCO Language of Respect Guidelines, Along With Suggested Compliant Versions Clause Noncompliant Compliant Do not blame the patients XX were screen failures XX were not eligible for the study Patient responded to... Patient had/experienced response to Responders/nonresponders Patients with response/no response Progressors Patients who had progressive disease Patients failed to respond to... Patients who did not have response to.... Patients achieved response Patient had/experienced response Patients are resistant to treatment| Patients who had progression on treatment Noncompliant patients Patients with barriers to adherence High-risk patients Patients with high-risk disease Respect role of the patients Patients managed with immunotherapy Patients had clear cell histology Patients treated with immunotherapy Do not dehumanize the patients Patients with clear cell RCC XX% were IMDC high risk XX% had IMDC high-risk disease Patients were classified as polymetastatic Patients were classified as having polymetastatic disease PD-L1-negative/PD-L1 -positive patients Patients with PD-L1-negative/PD-L1-positive disease Cases, subjects, controls Participants RCC patients Patients with RCC irAE patients Patients with irAE Patients were staged with MRI Disease staging was performed via MRI Immunotherapy users Patients on immunotherapy Patients treated with immunotherapy Smokers Patients who smoke XX mutants, wild types Patients with XX-mutated/wild-type disease Stage Ill patients Patients with stage Ill disease
November 20, 2025 at 3:38 PM
hannahrabrams.bsky.social
I wish we could unify mycharts across sites the way it is now connected on the provider end! Also hate that this is happening to you, @publichealthguy1.bsky.social
November 20, 2025 at 4:40 AM
hannahrabrams.bsky.social
Notably among ideas:
1. Capping extra $ paid for convenience &
2. Postmarketing review re: whether actually more convenient.
3. Clear eye to not allowing convenience to result in patent ever greening

Article here:
ascopubs.org/doi/10.1200/...

Original here:
ascopubs.org/doi/10.1200/...
ASCO Publications
Journals
ascopubs.org
November 19, 2025 at 3:49 AM
hannahrabrams.bsky.social
Can’t wait to see more people there! @tonybreu.bsky.social & @avrahamcoopermd.bsky.social are already figuring out tweetorials :)
November 19, 2025 at 3:43 AM
hannahrabrams.bsky.social
Yeah, I think you do need an algorithm to get some serendipity/hear people you wouldn't otherwise have followed. But weighting it to paid subscribers gets rid of that benefit. Hoping that Roon can find the right balance with it because it's run by former medtwitter fans
November 18, 2025 at 4:23 PM
hannahrabrams.bsky.social
The people who pay for X subscription get amplified, so it feels like my feed has fewer people in it because only the people paying come to the top.

It's a shame because my favorite part of #medtwitter was hearing from a wide range of people including students/trainees
November 18, 2025 at 4:09 PM
hannahrabrams.bsky.social
I have gone back in a limited way recently as part of a journal role. It is still alive but definitely different subjects and tone, & paid-subscriber amplification means hearing from fewer. Looking into alternatives - Roon is between Twitter/Linkedin and launching now www.roon.com/doctors/home
Roon for Doctors
A new way for doctors to learn from each other—fast. Roon for Doctors offers perspectives from medical experts on relevant questions in medicine.
www.roon.com
November 18, 2025 at 3:56 PM